Keyword: Drug Controller General of India
Pharma companies are risking the wrath of India's drugs regulator by ignoring a demand for clinical trials of combination drugs.
Major out-of-pocket market India could see sales of Opdivo and Keytruda by the end of 2016.
Wednesday, June 22, 2016
India's drug regulator says 200 drugmakers in the country, including major local companies such as Mumbai-based Cipla and multinational Pfizer, are being inspected for producing poor-quality medicines.
Roche has filed a lawsuit challenging an application for a biosimilar of Avastin in India.
India said a manufacturing halt on antifungal therapy Liposomal Amphotericin B has been sought through state regulators on 10 makers across 6 states.
India's health minister may ask the Supreme Court of India to provide an overall ruling on a ban of fixed-dose drug combinations made in March as challenges multiply in lower courts.